NeuBase Therapeutics, Inc.
NBSEDelisted May 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173281
NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding NeuBase Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 45 | 43 | −2 |
| Shares | 12.4M | 12.8M | +398.8K (+3.2%) |
| Value | $23.3M | $13.4M | −$9.88M (−42.5%) |
New holders (5)
Institutions that held NeuBase Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kestra Advisory Services, LLC | 510,678 | $536.0K | 0.01% |
| Charles Schwab Investment Management Inc | 29,716 | $32.0K | 0.00% |
| UBS Group AG | 2,457 | $3.00K | 0.00% |
| Venture Visionary Partners LLC | 665 | $698 | 0.00% |
| Schonfeld Strategic Advisors LLC | 12,714 | $0 | 0.00% |
Sold out (7)
Institutions that held NeuBase Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Bank of New York Mellon Corp | 87,210 | $164.0K |
| D. E. Shaw & Co., Inc. | 37,416 | $70.0K |
| Two Sigma Advisers, LP | 25,350 | $48.0K |
| Susquehanna International Group, LLP | 18,339 | $34.0K |
| Millennium Management LLC | 17,375 | $33.0K |
| Two Sigma Investments, LP | 10,222 | $19.0K |
| Simplex Trading, LLC | 5,316 | $9.00K |